Skip to main content
♕ The Globe and Mail Trade Off
Canada's free stock market contest is live! Test your investing skills for a chance to win $5,000.Enter Now!Enter Now!
➜

Prestige Brand Holdings(PBH-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low66.00
Day High68.58
Open:67.38
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Prestige Brand Holdings

Select a category then submit the form to load news
Tipranks
Oppenheimer Sticks to Its Buy Rating for Prestige Consumer Healthcare (PBH)
Newswire.ca
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market
Tipranks
Oppenheimer Remains a Buy on Prestige Consumer Healthcare (PBH)
Tipranks
Prestige Consumer Healthcare Earnings Call Highlights Cash Strength
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Prestige Consumer Healthcare (PBH), McKesson (MCK) and Bristol-Myers Squibb (BMY)
Tipranks
Prestige Consumer Healthcare Reports Q3 Results, Narrows Outlook
Motley Fool
Prestige (PBH) Q3 2026 Earnings Call Transcript
GlobeNewswire
Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results
Tipranks
Analysts Offer Insights on Healthcare Companies: Prestige Consumer Healthcare (PBH) and Vericel (VCEL)
Tipranks
Oppenheimer Remains a Buy on Prestige Consumer Healthcare (PBH)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Prestige Consumer Healthcare (PBH), Boston Scientific (BSX)
GlobeNewswire
Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference
Tipranks
Prestige Consumer Healthcare Reports Q2 Fiscal 2026 Results
Motley Fool
Prestige (PBH) Q2 2026 Earnings Call Transcript
GlobeNewswire
Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results
Tipranks
Jefferies Remains a Hold on Prestige Consumer Healthcare (PBH)
GlobeNewswire
Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results
ACCESS Newswire
Sidoti Events, LLC's Virtual September Small-Cap Conference
GlobeNewswire
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
Tipranks
Prestige Consumer Healthcare’s Cautious Earnings Call Outlook
Tipranks
Prestige Consumer Healthcare Acquires Pillar5 Pharma for Expansion
Motley Fool
Prestige (PBH) Q1 Revenue Falls 6.6%
GlobeNewswire
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results
GlobeNewswire
Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results
GlobeNewswire
Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination
Zacks Investment Research
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
GlobeNewswire
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
Zacks Investment Research
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?
Zacks Investment Research
Is Bio-Techne Stock the Right Pick for Your Portfolio Now?
Is Bio-Techne Stock the Right Pick for Your Portfolio Now?
Zacks Investment Research
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Zacks Investment Research
Should Tandem Diabetes Stock Stay in Your Portfolio Now?
Should Tandem Diabetes Stock Stay in Your Portfolio Now?
Zacks Investment Research
Should You Continue to Hold Charles River Stock in Your Portfolio?
Should You Continue to Hold Charles River Stock in Your Portfolio?

Profile

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.